Lung cancer symptoms extend beyond respiratory issues and can manifest as shoulder pain. Tumors pressing on nearby nerves can ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

It invested in a robotic, noninvasive technology for biopsies of hard-to-reach lesions in the lungs and to remove suspected ...

Scientists are using artificial intelligence to better capture how healthy cells surrounding tumors influence cancer cell behavior and how those interactions can inform treatments.

ABSTRACT #207P: Phase 1 Study of Reirradiation ("ReRT”) with NBTXR3 (JNJ-1900) for Inoperable Locoregional Recurrent ...

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies ...

Teddi Mellencamp was diagnosed with melanoma in 2022. Since then, she's had multiple biopsies, surgeries and the cancer has metastasized to her brain and lung.

Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are ...

Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of re-irradiation with JNJ-1900 (NBTXR3) for patients ...